T. Rowe Price Associates’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Buy
188,043
+24,516
+15% +$43.9K ﹤0.01% 2759
2025
Q4
$306K Buy
163,527
+17,663
+12% +$33.9K ﹤0.01% 2634
2025
Q3
$187K Sell
145,864
-133,373
-48% -$181K ﹤0.01% 2810
2025
Q2
$347K Buy
279,237
+18,396
+7% +$21.2K ﹤0.01% 2465
2025
Q1
$308K Sell
260,841
-1,510,812
-85% -$2.32M ﹤0.01% 2463
2024
Q4
$3.24M Sell
1,771,653
-67,099
-4% -$131K ﹤0.01% 1425
2024
Q3
$3.13M Sell
1,838,752
-100,482
-5% -$165K ﹤0.01% 1441
2024
Q2
$2.66M Sell
1,939,234
-16,148
-0.8% -$32.6K ﹤0.01% 1436
2024
Q1
$7.33M Sell
1,955,382
-1,643,893
-46% -$9.63M ﹤0.01% 1156
2023
Q4
$35.3M Sell
3,599,275
-389,435
-10% -$3.18M ﹤0.01% 796
2023
Q3
$33.3M Buy
3,988,710
+98,788
+3% +$1.13M ﹤0.01% 788
2023
Q2
$51.7M Buy
3,889,922
+248,110
+7% +$3.02M 0.01% 698
2023
Q1
$42.2M Buy
3,641,812
+216,045
+6% +$2.15M 0.01% 725
2022
Q4
$28M Buy
3,425,767
+55,139
+2% +$475K ﹤0.01% 827
2022
Q3
$19.6M Sell
3,370,628
-6,913,462
-67% -$39.7M ﹤0.01% 912
2022
Q2
$45.5M Buy
10,284,090
+4,179,997
+68% +$25.4M 0.01% 905
2022
Q1
$55.5M Buy
6,104,093
+270,289
+5% +$3.11M 0.01% 936
2021
Q4
$118M Buy
5,833,804
+84,468
+1% +$2.04M 0.01% 713
2021
Q3
$145M Buy
5,749,336
+2,214,524
+63% +$65.6M 0.01% 647
2021
Q2
$124M Sell
3,534,812
-5,487
-0.2% -$160K 0.01% 710
2021
Q1
$118M Buy
3,540,299
+221,559
+7% +$7.75M 0.01% 721
2020
Q4
$86.1M Buy
3,318,740
+942,147
+40% +$16M 0.01% 782
2020
Q3
$23.5M Buy
2,376,593
+2,291,714
+2,700% +$13.2M ﹤0.01% 1112
2020
Q2
$293K Sell
84,879
-51,340
-38% -$175K ﹤0.01% 2254
2020
Q1
$417K Buy
136,219
+41,441
+44% +$170K ﹤0.01% 2064
2019
Q4
$487K Buy
94,778
+5,541
+6% +$28.2K ﹤0.01% 2157
2019
Q3
$460K Buy
89,237
+750
+0.8% +$4.2K ﹤0.01% 2136
2019
Q2
$535K Buy
88,487
+47,338
+115% +$332K ﹤0.01% 2089
2019
Q1
$298K Buy
41,149
+400
+1% +$2.89K ﹤0.01% 2294
2018
Q4
$302K Buy
40,749
+423
+1% +$2.68K ﹤0.01% 2279
2018
Q3
$218K Sell
40,326
-752
-2% -$3.23K ﹤0.01% 2444
2018
Q2
$146K Buy
41,078
+252
+0.6% +$699 ﹤0.01% 2497
2018
Q1
$84K Buy
40,826
+202
+0.5% +$525 ﹤0.01% 2511
2017
Q4
$107K Sell
40,624
-29,900
-42% -$105K ﹤0.01% 2500
2017
Q3
$370K Hold
70,524
﹤0.01% 2200
2017
Q2
$251K Buy
70,524
+24
+0% +$97 ﹤0.01% 2300
2017
Q1
$364K Hold
70,500
﹤0.01% 2179
2016
Q4
$268K Hold
70,500
﹤0.01% 2290
2016
Q3
$632K Buy
70,500
+54,600
+343% +$456K ﹤0.01% 1917
2016
Q2
$112K Sell
15,900
-15,000
-49% -$137K ﹤0.01% 2410
2016
Q1
$263K Hold
30,900
﹤0.01% 2208
2015
Q4
$406K Sell
30,900
-22,900
-43% -$205K ﹤0.01% 2040
2015
Q3
$197K Buy
53,800
+30,200
+128% +$148K ﹤0.01% 2293
2015
Q2
$136K Hold
23,600
﹤0.01% 2420
2015
Q1
$138K Hold
23,600
﹤0.01% 2425
2014
Q4
$185K Sell
23,600
-15,200
-39% -$97.3K ﹤0.01% 2374
2014
Q3
$191K Hold
38,800
﹤0.01% 2358
2014
Q2
$240K Hold
38,800
﹤0.01% 2283
2014
Q1
$208K Buy
38,800
+9,500
+32% +$60K ﹤0.01% 2305
2013
Q4
$153K Sell
29,300
-33,800
-54% -$155K ﹤0.01% 2363
2013
Q3
$349K Sell
63,100
-20,000
-24% -$69.4K ﹤0.01% 2047
2013
Q2
$209K Buy
+83,100
New +$207K ﹤0.01% 2199

Other funds holding PACB